19 October 2023
Top hires for VC & PE portfolio companies Q3-2023
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
Function | Focus area | Location |
---|---|---|
CEO | Medical equipment | France |
CEO (US-based) | CAR-T therapies | UK |
Chief Product Officer | EHR data platform | Spain |
Chief Scientific Officer | tRNA-based therapeutics | US |
Chief Financial Officer | R&D consulting services | US |
Group Chief Financial Officer | Outpatient services (aesthetic medicine) | Switzerland |
Chief Business Officer (US-based) | AI for drug discovery | Central & Eastern Europe |
Head of Business Development, North America | Contract research organisation | Canada |
VP Clinical Affairs | Analgesic products | US |
VP Operations | Bio-electrical implantable devices | UK |
VP Global Program Lead (US-based) | Multi-modality biotech | UK |
Country Regional Director | Veterinary services | Nordics |
Chair | Protein therapeutics | UK |
Board Director | Oncology drug discovery | Germany |
Newly opened projects include:
Function | Focus area | Location |
---|---|---|
CEO | Medical devices | Israel |
CEO | Outpatient services | Germany |
Country CEO | Healthcare services | Sweden |
Chief Strategy Officer | Endoscopic devices | Israel |
Chief Product Officer | Medical information services | UK |
Chief Medical Officer | Small molecules | Italy |
Head of Drug Metabolism & Pharmacokinetics | CNS platform technology | UK |
Head of TechOps | Radiopharmaceuticals | China |
VP Business Development | Transplant technology | US |
VP Sales | Digital pathology solutions | France |
Managing Director | Private equity investor | US |
Head of Alliance Management | Life sciences incubator | UK |
General Manager Infectious Diseases | Biocluster | France |
Chair | Digital therapeutics/ devices | US |
Board Director | Precision contract manufacturing | US |